Clinical neurology and epidemiology of the major neurodegenerative diseases

MG Erkkinen, MO Kim… - Cold Spring Harbor …, 2018 - cshperspectives.cshlp.org
Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in
older adults. Most clinicians who care for the elderly are not trained to diagnose these …

Assessment and management of behavioral and psychological symptoms of dementia

HC Kales, LN Gitlin, CG Lyketsos - Bmj, 2015 - bmj.com
Behavioral and psychological symptoms of dementia include agitation, depression, apathy,
repetitive questioning, psychosis, aggression, sleep problems, wandering, and a variety of …

Does private equity investment in healthcare benefit patients? Evidence from nursing homes

A Gupta, ST Howell, C Yannelis… - Evidence from Nursing …, 2021 - papers.ssrn.com
The past two decades have seen a rapid increase in Private Equity (PE) investment in
healthcare, a sector in which intensive government subsidy and market frictions could lead …

Evidence-based nonpharmacological practices to address behavioral and psychological symptoms of dementia

K Scales, S Zimmerman, SJ Miller - The Gerontologist, 2018 - academic.oup.com
Abstract Background and Objectives To draw from systematic and other literature reviews to
identify, describe, and critique nonpharmacological practices to address behavioral and …

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm

DT Maust, HM Kim, LS Seyfried, C Chiang… - JAMA …, 2015 - jamanetwork.com
Importance Antipsychotic medications are associated with increased mortality in older adults
with dementia, yet their absolute effect on risk relative to no treatment or an alternative …

Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel

HC Kales, LN Gitlin, CG Lyketsos… - Journal of the …, 2014 - Wiley Online Library
Noncognitive neuropsychiatric symptoms (NPS) of dementia (aggression, agitation,
depression, anxiety, delusions, hallucinations, apathy, disinhibition) affect individuals with …

Cholinesterase inhibitors for Alzheimer's disease

JS Birks… - Cochrane database …, 1996 - cochranelibrary.com
Background** This review is awaiting update with a new protocol. The methods used for the
review were acceptable when the review was published but do not meet contemporary …

Caregiver burden among dementia patient caregivers: a review of the literature

L Etters, D Goodall, BE Harrison - Journal of the American …, 2008 - journals.lww.com
Caregiver burden among dementia patient caregivers: A review... : Journal of the American
Association of Nurse Practitioners Caregiver burden among dementia patient caregivers: A …

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

LS Schneider, KS Dagerman, P Insel - Jama, 2005 - jamanetwork.com
ContextAtypical antipsychotic medications are widely used to treat delusions, aggression,
and agitation in people with Alzheimer disease and other dementia; however, concerns …

Nonpharmacologic management of behavioral symptoms in dementia

LN Gitlin, HC Kales, CG Lyketsos - Jama, 2012 - jamanetwork.com
Behavioral symptoms such as repetitive speech, wandering, and sleep disturbances are a
core clinical feature of Alzheimer disease and related dementias. If untreated, these …